Skip to Content

Erbitux Sales Data

Last updated: February 2014 (updated quarterly).
The following data shows Erbitux U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q2 2012 95 (4) -2.10% -1.50%
Q1 2012 99 (2) 2.30% 3.91%
Q4 2011 97 (7) -0.15% 0.79%
Q3 2011 90 (3) -2.48% -1.93%
Q2 2011 93 (2) -0.89% -0.38%
Q1 2011 95

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

March 10, 2016Elderly With Advanced Colon Cancer Often Get Costly, Dubious Treatments: Study
December 23, 2013EU OKs Erbitix Labeling
July 9, 2012FDA Oks Screening Test for Colon Cancer Drug
November 7, 2011Erbitux Approval Expanded to Include Head and Neck Cancer
June 9, 2011Chemo for Late-Stage Cancer Patients May Be Unjustified
December 20, 2010Rash Due to Lung Cancer Drug May Be Linked to Better Survival
October 26, 2010New Insights on Who Should Take Erbitux for Colon Cancer
October 11, 2010Erbitux Drug Fails In Colon Cancer Study That May Limit Its Use
April 1, 2009Erbitux May Help Some With Colorectal Cancer
October 22, 2008Colon Cancer Drug Won't Help Those With Certain Gene Mutation